Amyloidosis trials in Mexico

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  Where

  Mexico City

  Age

  18 years to 90 years

  People

  1,200 worldwide

  Run by

  Intellia Therapeutics

  See details and how to joinNCT06128629 · EU 2023-507220-23-00
• Phase 3Taking people
  TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  Where

  Tlalpan

  Age

  18 years to 85 years

  People

  1,750 worldwide

  Run by

  Alnylam Pharmaceuticals

  See details and how to joinNCT07052903 · EU 2024-519917-72-00
• Phase 3Taking people
  TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

  Where

  Guadalajara, Tlalpan

  Age

  18 years to 85 years

  People

  125 worldwide

  Run by

  Alnylam Pharmaceuticals

  See details and how to joinNCT07223203 · EU 2025-522544-40-00
• Phase 3Taking people
  Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  Where

  Tlalpan

  Age

  18 years to 75 years

  People

  587 worldwide

  Run by

  Eidos Therapeutics, a BridgeBio company

  See details and how to joinNCT06563895 · EU 2024-513547-82-00